Profiling Activities of Transcription Factors in Breast Cancer Cell Lines
- 1 June 2006
- journal article
- research article
- Published by Mary Ann Liebert Inc in ASSAY and Drug Development Technologies
- Vol. 4 (3) , 293-305
- https://doi.org/10.1089/adt.2006.4.293
Abstract
Transcription factors (TFs) are critical regulators of cell growth and differentiation, whose dysfunction is associated with many human diseases, including cancer. To facilitate the discovery of functionally altered TFs among the approximately 2,000 human TFs, we (Panomics, Inc., Fremont, CA) developed a Protein/DNA array technology that can be used to profile the activities of multiple TFs simultaneously. In this study, we applied this technology to examine the TF activities in three different breast cancer cell lines: MCF7 (estrogen receptor [ER] +, tamoxifen-sensitive), T47D (ER+, tamoxifen-resistant), and HCC1806 (ER–, tamoxifen-resistant). We compared the differences in TF activity in these cells lines following treatment with estradiol or tamoxifen. We found a number of TF activities unique to each of these cell lines. In addition to verifying previous findings, the novel findings of this study provide a more comprehensive view of the differences in the response of these cancer lines to estrogen and tamoxifen.Keywords
This publication has 21 references indexed in Scilit:
- ACTR/AIB1 Functions as an E2F1 Coactivator To Promote Breast Cancer Cell Proliferation and Antiestrogen ResistanceMolecular and Cellular Biology, 2004
- Use of an array technology for profiling and comparing transcription factors activated by TNFα and PMA in HeLa cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Gene expression in diagnosisNature, 2000
- The Estrogen Receptor Enhances AP-1 Activity by Two Distinct Mechanisms with Different Requirements for Receptor Transactivation FunctionsMolecular Endocrinology, 1999
- Transcription factors and breast cancerEndocrine-Related Cancer, 1998
- Cell Growth Arrest and Induction of Cyclin-Dependent Kinase Inhibitor p21 WAF1/CIP1 Mediated by STAT1Science, 1996
- Cell Cycle Kinetic Effects of Tamoxifen on Human Breast Cancer CellsAnnals of the New York Academy of Sciences, 1993
- Breast Cancer Prognostic Factors: Evaluation GuidelinesJNCI Journal of the National Cancer Institute, 1991